Share tips of the week – 14 October
MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
Three to buy
Tesco
The Mail on Sunday
Tesco is “dealing with a long shopping list of problems”, including the rising cost of food, evident in smaller basket sizes. The company has to adapt to changing circumstances “without losing share to discounters such as Aldi and Lidl”, which might affect margins and profits. However, the group increased its interim dividend by 20% and is returning cash to shareholders via a buyback. The company has “plenty of cash, good relationships with suppliers and... real expertise in offering value to customers”. That makes the shares a buy for those willing to sit through the turbulence. 205p
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Crestchic
Shares
Industrial manufacturer Crestchic’s shares have rallied by 40% over the past three months but they still trade on just 9.9 times analysts’ latest earnings-per-share forecast for 2023. The company sold off its Australian drilling tools division in March, which left it to focus on its load banks business . This equipment is used to test power systems in sectors operating everything from data centres to oil, gas and mining operations. Data centres are a particularly lucrative sector thanks to “exponential growth” in cloud computing. Crestchic looks well positioned to take advantage of demand for these in the US. 270p
Croda
The Sunday Times
FTSE 100 chemicals giant Croda sold its industrial chemicals operations for $1bn last year, and now focuses mainly on life sciences and beauty products. The company benefited from Covid-19 because it provided the lipid nanoparticles necessary for Pfizer’s vaccine. But the company “has purposes beyond the pandemic”. Its technology could be used in mRNA therapies, which are becoming more popular, and its beauty and skincare businesses provide scope for global growth. 6,748p
Two to sell
Dignity
Investors’ Chronicle
Funeral provider Dignity announced heavy losses for the half-year to 1 July, along with a “chunky impairment charge” of £63m owing to “slower funeral market-share growth” and an increase in cremations over burials. The company, which runs 750 locations across the UK, is also struggling with recruitment. It has suffered “severe” staff shortages since January and currently has over 400 vacancies. The downturn in revenue was unsurprising given the lower death rate compared with the same period the year before. Deaths were down by 6% to 319,000. The company’s new pricing model was meant to make it more competitive but it has yet to deliver. It’s set to adjust prices again in October, but based on its results “the plan isn’t working” and the ongoing labour shortage remains a concern. Sell. 353p
Vaxart
Motley Fool
Biotech Vaxart develops oral vaccines and is working on one for Covid-19, which “would be a big deal” – many people would prefer to avoid a needle. Still, investors worry that demand for these products will slide; 68% of the world’s population has received at least one dose of the vaccine. The booster market could be an opportunity but Vaxart will have to prove its candidate is safe and effective, and “it still has a long road ahead”. There are other biotech firms with more solid investment cases. Avoid. $1.93
...and the rest
Investors’ Chronicle
Banks are not immune to turbulent markets but larger ones, such as Lloyds Banking Group, have the “structural advantage” to withstand it. The shares look good value, too. Buy (42p). Google owner Alphabet’s valuation does not appear to reflect its “strong market position”; it is both gaining ground in advertising and continuing to grow its cloud business. Buy ($98.64).
The Mail on Sunday
Greggs should keep benefiting from its “more affordable” image as consumers save money. The stock is trading on a price/earnings (p/e) ratio of 15, and it yields over 3%. “Historically the ratio is over 17 times. Worth a nibble” (1,798p).
The Times
Shares in defence contractor BAE Systems have jumped by 45% since February, when Russia invaded Ukraine. Demand for its technology is likely to increase, and shares are modestly priced. Buy (834p). Price-comparison site Moneysupermarket’s half-year results were positive, although the government’s takeover of the energy market hampered performance. The company has acquired two new businesses and there is further scope to “consolidate its market leadership”. Buy (193p).
The Telegraph
Radiation-detector specialist Kromek, engineering-services group Tekmar, online wine group Naked Wines and online fashion retailer Boohoo are no longer worth the tax breaks afforded to their investors thanks to their Aim-listed status. The companies look “ill-placed to survive what looks likely to be a tough few months”, so it is time to sell (8.05p, 8.3p, 81.4p, 37.6p).
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
The best houses for sale with wildflower meadows
The best houses for sale with wildflower meadows – from a 1770s mill house in Petersfield, Hampshire, to a cottage in Fittleworth, West Sussex
By Natasha Langan Published
-
Will a Santa Rally bring festive cheer to investor portfolios this year?
Investors will be hoping for a seasonal stock market boost in December
By Marc Shoffman Published
-
Halifax: House price slump continues as prices slide for the sixth consecutive month
UK house prices fell again in September as buyers returned, but the slowdown was not as fast as anticipated, latest Halifax data shows. Where are house prices falling the most?
By Kalpana Fitzpatrick Published
-
Rents hit a record high - but is the opportunity for buy-to-let investors still strong?
UK rent prices have hit a record high with the average hitting over £1,200 a month says Rightmove. Are there still opportunities in buy-to-let?
By Marc Shoffman Published
-
Pension savers turn to gold investments
Investors are racing to buy gold to protect their pensions from a stock market correction and high inflation, experts say
By Ruth Emery Published
-
Where to find the best returns from student accommodation
Student accommodation can be a lucrative investment if you know where to look.
By Marc Shoffman Published
-
Best investing apps
Looking for an easy-to-use app to help you start investing, keep track of your portfolio or make trades on the go? We round up the best investing apps
By Ruth Emery Last updated
-
The world’s best bargain stocks
Searching for bargain stocks with Alec Cutler of the Orbis Global Balanced Fund, who tells Andrew Van Sickle which sectors are being overlooked.
By Andrew Van Sickle Published
-
Revealed: the cheapest cities to own a home in Britain
New research reveals the cheapest cities to own a home, taking account of mortgage payments, utility bills and council tax
By Ruth Emery Published
-
UK recession: How to protect your portfolio
As the UK recession is confirmed, we look at ways to protect your wealth.
By Henry Sandercock Last updated